Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
I'm a hypnotherapist who helps day traders who are losing money. Here's why I think hypnosis works. - 219 Peculiar Films You Shouldn't Watch With Your Mum
- 35 Christmas movies to stream for less with this Paramount+ Black Friday deal
- 4Select Your Definitive Pizza Decision
- 5Cognizant Couture d: A Survey of \Moral Decisions and Sharp Looks\ Maintainable Style
- Creative Do-It-Yourself Ventures for Each Expertise Level
- Supercharge Your Remote Work Arrangement with These Game-Changing Instruments
- 2024's Hot Games: Must-Play Titles of the Year
- You finally got a doctor's appointment. Here's how to get the most out of it
- Eating Brie, Gouda, cheddar may lower dementia risk, new study says
- Taylor Momsen explains why she quit 'Gossip Girl': 'I really didn't want to be there'
- Tech for Efficiency: Applications and Apparatuses to Accomplish More
- Creative Style: 10 Architects Reclassifying the Business
- PFAS in pregnant women’s drinking water puts their babies at higher risk, study finds
